Suppr超能文献

改良预存式自体红细胞单采术在多节段脊柱融合术中的临床应用:一项单中心回顾性研究

Clinical application of a modified predeposit autologous red blood cell apheresis in multistage spinal fusion: a single-center retrospective study.

作者信息

Xu Xiao-Ping, Que Wen-Jun, Yu Ze-Bo, Shen Jie-Liang, Hu Zhen-Ming, Yang Xiao-Liang, Hao Jie

机构信息

The Department of Orthopedics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

The Department of Blood Transfusion, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

出版信息

Front Med (Lausanne). 2023 May 15;10:1149093. doi: 10.3389/fmed.2023.1149093. eCollection 2023.

Abstract

PURPOSE

This study aimed to evaluate the efficacy and safety of predeposit autologous RBC apheresis (PARA) in patients undergoing multilevel spinal fusion surgery.

METHODS

A total of 112 patients from January 2020 to June 2022 were divided into two groups according to PARA: the PARA group ( = 51) and the control group ( = 61). The baseline characteristics of the patients, outcomes, transfusion cost, hospitalization cost, length of stay, complications, and changes in hemoglobin and hematocrit levels between the two groups were compared.

RESULTS

The baseline characteristics were similar in both groups. No significant differences were found in functional outcomes, including VAS score ( = 0.159), ODI score ( = 0.214), JOA score ( = 0.752), and SF-36 score ( = 0.188) between the PARA and control groups. The amount and rate of intraoperative and perioperative allogeneic RBC transfusion were significantly higher in the control group than in the PARA group ( < 0.001). The postoperative (9.04 ± 3.21 vs. 11.05 ± 3.84, = 0.004) and total length of stay (15.78 ± 3.79 vs. 17.36 ± 4.08, = 0.038) in the PARA group were significantly lower than those in the control group, respectively. Despite no difference in hospitalization cost ( = 0.737), the total blood transfusion cost in the PARA group was significantly lower, compared with the control group ( < 0.001). For safety evaluation, there were no significant differences in Hb and Hct levels between the two groups at admission, on postoperative day 1, and postoperative day 3, respectively ( > 0.05). Moreover, the number of postoperative infections in the PARA group was significantly lower than that in the control group ( = 0.038).

CONCLUSION

PARA was a novel, safe, and highly efficient technique for mass autologous blood preparation in a quite short preparation time. This method could significantly reduce the amount of allogeneic blood transfusion and length of stay, which could provide a theoretical basis for following clinical practice about the technique.

摘要

目的

本研究旨在评估预存自体红细胞单采术(PARA)在接受多节段脊柱融合手术患者中的疗效和安全性。

方法

将2020年1月至2022年6月期间的112例患者根据是否采用PARA分为两组:PARA组(n = 51)和对照组(n = 61)。比较两组患者的基线特征、结局、输血费用、住院费用、住院时间、并发症以及血红蛋白和血细胞比容水平的变化。

结果

两组的基线特征相似。PARA组和对照组在功能结局方面无显著差异,包括视觉模拟评分(VAS评分,P = 0.159)、脊柱功能障碍指数(ODI评分,P = 0.214)、日本骨科学会(JOA)评分(P = 0.752)和简明健康状况调查量表(SF - 36)评分(P = 0.188)。对照组术中及围手术期异体红细胞输注量和输注率均显著高于PARA组(P < 0.001)。PARA组的术后住院时间(9.04 ± 3.21天 vs. 11.05 ± 3.84天,P = 0.004)和总住院时间(15.78 ± 3.79天 vs. 17.36 ± 4.08天,P = 0.038)均显著低于对照组。尽管住院费用无差异(P = 0.737),但PARA组的总输血费用显著低于对照组(P < 0.001)。在安全性评估方面,两组患者入院时、术后第1天和术后第3天的血红蛋白和血细胞比容水平分别无显著差异(P > 0.05)。此外,PARA组术后感染例数显著低于对照组(P = 0.038)。

结论

PARA是一种在较短准备时间内大量制备自体血的新型、安全且高效的技术。该方法可显著减少异体输血量和住院时间,可为该技术后续的临床应用提供理论依据。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验